Airis Pharma Private Limited - Company Profile

Q: Who are the current directors of Airis Pharma Private Limited?

The current directors of Airis Pharma Private Limited are Venkata Bhattaram Chandra Sekhar, Mohan Reddy Patalolla, Ganji Kishore Kumar, Ajoy Pavan Kumar Koppolu Yerakaliah, Gantla Shailaja, Srilalitha Bhattaram, Suchritha Reddy Patlolla.

It is a pharma private limited company based in Quthbullapur Mandal, Telangana, India, established in 2013.

2013 Quthbullapur Mandal, Telangana, India Active

Last Updated: February 23, 2026

Access Report

About Airis Pharma Private Limited

Airis Pharma Private Limited, a active private limited company, was established on 19 August 2013 in Quthbullapur Mandal, Telangana, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U24232TG2013PTC089550. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹7.52 Cr.

It upholds a compliant status. Employing 47 professional, Its leadership includes Venkata Bhattaram Chandra Sekhar (Director), Mohan Reddy Patalolla (Director), Ganji Kishore Kumar (Director). Past directors included Mohan Reddy Patalolla, Bhagwant Reddy Gantla, Ganji Kishore Kumar. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No 64 And 65, Survey No. 342, Aleap Industrial Estate, Gajularamaram V, Illage,, Quthbullapur Mandal, Telangana, 500078.

Company Details

CIN/LLPIN
U24232TG2013PTC089550
Registration Number
089550
Incorporation Date
19 August 2013
Authorized Capital
₹10.00 Cr
Paid-Up Capital
₹7.52 Cr
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 10.00 Cr as on 23-02-2026
Paid Up Capital ₹ 7.52 Cr as on 23-02-2026
Company Age 12 Year, 6 Months
Last Filing with ROC 31 Mar 2024
Revenue Growth **** 261.33% (FY 2022)
Profit Growth **** 414.86% (FY 2022)
Ebitda **** 1163.57% (FY 2022)
Net Worth 4.65% (FY 2022)
Total Assets -3.30% (FY 2022)

Comprehensive Company Insights

Explore comprehensive insights into Airis Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Airis Pharma Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Venkata Bhattaram Chandra Sekhar	Director	21 Jul 2025	Current
Mohan Reddy Patalolla	Director	16 Jan 2017	Current
Ganji Kishore Kumar	Director	30 Aug 2013	Current
Ajoy Pavan Kumar Koppolu Yerakaliah	Director	30 Aug 2013	Current
Gantla Shailaja	Director	21 Sep 2020	Current
Srilalitha Bhattaram	Director	21 Sep 2020	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	11 Feb 2017	Past
Pramod Abcsdd	Director	05 Jan 2026	Past
Pramod Abcsdd	Director	06 Jul 2020	Past
Pramod Abcsdd	Additional Director	21 Feb 2018	Past
Pramod Abcsdd	Managing Director	02 Feb 2020	Past
Pramod Abcsdd	Additional Director	31 Dec 2020	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Airis Pharma.

Airis Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 261.33% increase. The company also saw a substantial improvement in profitability, with a 414.86% increase in profit. The company's net worth moved up by a moderate rise of 4.65%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

261.33%

*******

Revenue from Operations

*******

287.61%

*******

Total Assets

*******

-3.30%

*******

Profit or Loss

*******

414.86%

*******

Net Worth

*******

4.65%

*******

EBITDA

*******

1163.57%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Airis Pharma?

In 2022, Airis Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Airis Pharma?

Airis Pharma has a workforce of 47 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Airis Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Airis Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Airis Pharma

Recent Activity within the Organization

Director Appointment

The activity Suchritha Reddy Patlolla was appointed as a Director was appointed as a Director on 05 Jan 2026 & has been associated with this company since 1 month 26 days . was completed.
05 Jan 2026
Director Appointment

Venkata Bhattaram Chandra Sekhar was appointed as a Director was appointed as a Director on 21 Jul 2025 & has been associated with this company since 7 months 13 days . was recorded as a recent event.
21 Jul 2025
Annual General Meeting

Airis Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
30 Sep 2024
Balance Sheet

Airis Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
31 Mar 2024
Director Appointment

Gantla Shailaja was appointed as a Director was appointed as a Director on 21 Sep 2020 & has been associated with this company since 5 years 5 months . was recorded as a recent event.
21 Sep 2020
Director Appointment

Progress on Srilalitha Bhattaram was appointed as a Director was appointed as a Director on 21 Sep 2020 & has been associated with this company since 5 years 5 months . was documented.
21 Sep 2020

Explore recent activity and updates - View Recent Activity